Submitted by Anonymous (not verified) on 23 May 2025 - 14:29
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Blitzima, rituximab, Date of authorisation: 13/07/2017, Revision: 23, Status: Authorised